A Case Report on Therapeutic Optimization and Cardiometabolic Benefits of Semaglutide Therapy in Type 2 Diabetes Mellitus: Case Report. (2026). Journal of Pharma Insights and Research, 4(2), 252-258. https://doi.org/10.69613/ss2yp015